These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9807218)

  • 21. Species differences in chemical carcinogenesis of the thyroid gland, kidney and urinary bladder.
    Dybing E; Sanner T
    IARC Sci Publ; 1999; (147):15-32. PubMed ID: 10457907
    [No Abstract]   [Full Text] [Related]  

  • 22. Bracken fern-induced bladder tumors in guinea pigs. A model for human neoplasia.
    Brasileiro Filho G; Santos RC; Silva ME
    Am J Pathol; 1996 Oct; 149(4):1417-8. PubMed ID: 8863688
    [No Abstract]   [Full Text] [Related]  

  • 23. Epigenetic mechanisms of nickel carcinogenesis.
    Salnikow K; Costa M
    J Environ Pathol Toxicol Oncol; 2000; 19(3):307-18. PubMed ID: 10983897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer risk assessment of direct acting carcinogens.
    Zito R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):273-8. PubMed ID: 10606168
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of carcinogenic veterinary drugs in the veterinary clinic, an unacceptable risk for people?].
    Pellicaan C; Teske E; Vaarkamp H; Willemse T;
    Tijdschr Diergeneeskd; 2002 Dec; 127(23):734-5. PubMed ID: 12491976
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to Klaunig J.E. et al.'s "Epigenetic mechanisms of chemical carcinogenesis".
    Preston RJ
    Hum Exp Toxicol; 2000 Oct; 19(10):569-70; discussion 571-2. PubMed ID: 11211996
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of nonhuman primates to carcinogens of human relevance.
    Schoeffner DJ; Thorgeirsson UP
    In Vivo; 2000; 14(1):149-56. PubMed ID: 10757072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to "Epigenetic mechanisms of chemical carcinogenesis" by James E. Klaunig, Lisa M. Kamendulis, and Xu Yong.
    DeAngelo AB
    Hum Exp Toxicol; 2000 Oct; 19(10):561-2; discussion 571-2. PubMed ID: 11211993
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular mechanisms of nickel carcinogenesis.
    Costa M
    Biol Chem; 2002 Jun; 383(6):961-7. PubMed ID: 12222685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Search for agents responsible for DNA damaging and hazardous for humans: certain achievements in cancer etiology research].
    Bartsch H
    Vopr Onkol; 2004; 50(3):261-5. PubMed ID: 15318698
    [No Abstract]   [Full Text] [Related]  

  • 32. [Molecular epidemiology in the identification of subjects susceptible to the effects of environmental carcinogens].
    Izzotti A; Cartiglia C; De Flora S
    Ann Ig; 1999; 11(6):439-49. PubMed ID: 10596433
    [No Abstract]   [Full Text] [Related]  

  • 33. Tobacco carcinogens, their biomarkers and tobacco-induced cancer.
    Hecht SS
    Nat Rev Cancer; 2003 Oct; 3(10):733-44. PubMed ID: 14570033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some reflections and speculations about chemical carcinogenesis.
    Heidelberger C
    Proc Can Cancer Conf; 1967; 7():326-50. PubMed ID: 4860287
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of organ specificity in chemical carcinogenesis.
    Dong ZA; Jeffrey AM
    Cancer Invest; 1990; 8(5):523-33. PubMed ID: 2265374
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinogenesis, cancer therapy and chemoprevention.
    Blagosklonny MV
    Cell Death Differ; 2005 Jun; 12(6):592-602. PubMed ID: 15818400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopropylactic approaches against chemical carcinogenesis.
    De Buck SS; Muller CP
    Vaccine; 2005 Mar; 23(17-18):2403-6. PubMed ID: 15755636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.
    Song S; Liem A; Miller JA; Lambert PF
    Virology; 2000 Feb; 267(2):141-50. PubMed ID: 10662610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer and metals and metal compounds: part I--carcinogenesis.
    Desoize B
    Crit Rev Oncol Hematol; 2002 Apr; 42(1):1-3. PubMed ID: 11923064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.